Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

Taking dutasteride every other day works as well as daily and better preserves sexual function.

Finasteride and dutasteride are equally effective and safe for treating BPH.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

CARASIL, a rare genetic disorder, was confirmed in an Arabic woman, highlighting its rarity and need for stroke prevention.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Tamsulosin may slightly increase dementia risk compared to other treatments for enlarged prostate.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Serenoa repens is a common and effective plant-based treatment for mild-to-moderate prostate enlargement symptoms.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Treatments for urinary symptoms often cause ejaculatory problems.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Some medications and supplements can affect male fertility, with some improving and others harming sperm quality.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Alpha-blockers are recommended first for recent CP/CPPS, while antimicrobials are not advised for long-term cases.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.